Latest Aptar News & Updates

See the latest news and media coverage for Aptar. We track all announcements, press releases, and industry mentions in real time, all in one place.

Aptar

Drug and consumer product dosing, dispensing and protection technologies

aptar.com

Headquarters: United States
Company type: Public company
Number of employees: 10,000+

Last updated Today

Latest news about Aptar

In short: Aptar named Gael Touya as its new CEO to succeed Stephan Tanda, reported an 11% sales increase for Q1 2026, and advanced several drug delivery patents.

Company announcements

June 10 Aptar

Aptar secures USPTO allowance for N-Sorb technology

The first-of-its-kind packaging-delivered approach addresses nitrosamine risk in pharmaceuticals.

May 28 Aptar

Aptar announces patents and preclinical data for GLP-1 delivery

The program aims to enable inhaled and nasal delivery of GLP-1 therapies using spray-dried and powder processing.

May 26 Aptar

Aptar addresses Annex 1 considerations for elastomeric closures

It highlights three common gaps in contamination control, particle management, and component qualification.

April 30 Aptar

Aptar reports first quarter 2026 financial results

Sales up 11%, net income down 8%; adjusted EPS $1.19.

Media coverage

May 25 The Globe and Mail

AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot

AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an...

May 11 Our Midland

Aptar Midland breaks ground on $1 million facility expansion

Aptar Midland broke ground May 7 on an 8,600-square-foot, $1 million-plus expansion of its facility. The facility is currently 35,000 square feet, with about 11,000...

May 9 Crain's Chicago Business

Aptar names Gael Touya CEO with Stephan Tanda retiring - Crain's Chicago Business

The company that turned the condiment world upside-down is now turning drug delivery on its nose at the same time it elevates its pharmaceutical leader...

May 9 BioSpace

Aptar Reports First Quarter 2026 Results - BioSpace

The injectables division delivered another quarter of strong, double-digit growth. Consumer dispensing also contributed positively, with volume growth across Beauty and Closures, supported by robust...

Never miss news about Aptar

Track Aptar and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Aptar competitors & trending companies

Browse news for competitors to Aptar and other trending companies.